An exceptional safety profile has been shown in a large number of cell therapy clinical trials
that use mesenchymal stromal cells (MSCs). However, reliable potency assays are still …

Mesenchymal stromal cells (MSCs) have been the subject of clinical trials for more than a
generation, and the outcomes of advanced clinical trials have fallen short of expectations …

Engineered biomaterials are materials specifically designed to interact with biological
systems for biomedical applications. This paper offers the comprehensive analysis of global …

In 2006, the induced pluripotent stem cell (iPSC) was presented to the world, paving the way
for the development of a magnitude of novel therapeutic alternatives, addressing a diverse …

Pluripotent stem cells (PSCs) hold great potential for novel therapeutic approaches to
regenerate or replace functionally impaired tissues. Since the introduction of the induced …

Despite the various mechanisms that involved in the pathogenesis of Alzheimer's disease
(AD), neuronal damage and synaptic dysfunction are the key events leading to cognition …

The promise of stem cell (SC) therapies to restore functions of damaged tissues and organs
brings enormous hope to patients, their families, loved ones, and caregivers. However, limits …

Over the last decade, the acceleration in the clinical use of mesenchymal stromal cells
(MSCs) has been nothing short of spectacular. Perhaps most surprising is how little we know …

Mesenchymal stem cells (MSCs) represent an invaluable asset for the field of cell therapy.
Human Bone marrow-derived MSCs (hBM-MSCs) are one of the most commonly used cell …

The advances and success of umbilical cord–derived mesenchymal stromal cells (UC-
MSCs) in experimental disease animal models have fueled the development of targeted …